Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-16-014984

VP, Finance sold 160 shares at $3.46 ($554)

From the SEC's structured data for this filing

Trades in this filing

Selby Brian L. · VP, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-02-29 Sale : show line 1 in the form −160 $3.46 $554 4,140 D
Open-market sales · 160 sh · avg $3.46 · $554
Loading xslF345X03/doc4.xml…